Dr Mark Anthony Valdez, MD | |
888 S King St, Honolulu, HI 96813-3097 | |
(808) 522-4000 | |
Not Available |
Full Name | Dr Mark Anthony Valdez |
---|---|
Gender | Male |
Speciality | Critical Care (intensivists) |
Experience | 15 Years |
Location | 888 S King St, Honolulu, Hawaii |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1417252362 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RC0200X | Internal Medicine - Critical Care Medicine | MD-17975 (Hawaii) | Primary |
207R00000X | Internal Medicine | A115142 (California) | Secondary |
Facility Name | Location | Facility Type |
---|---|---|
Straub Clinic And Hospital | Honolulu, HI | Hospital |
Pali Momi Medical Center | Aiea, HI | Hospital |
Wilcox Memorial Hospital | Lihue, HI | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Aloha Critical Care Associates Llp | 3870522956 | 13 |
News Archive
An in-depth study on the regulation of adenosine-to-inosine (A-to-I) RNA editing by researchers from the Cancer Science Institute of Singapore at the National University of Singapore found that a protein, known as DHX9, acts as a bidirectional regulator of the molecular process which is linked to various types of cancer such as esophageal cancer.
Two chemical engineering professors at Rensselaer Polytechnic Institute are contributing to a collaboration among academia, industry, and the federal government to develop a method for rapidly manufacturing biologic drugs.
Lexicon Pharmaceuticals, Inc. announced today that it is progressing into the placebo-controlled portion of its Phase 2 clinical trial of LX4211 in patients with type 1 diabetes, having successfully completed the open-label, pioneer portion of the trial.
About half of the long-term unemployed and under-employed in a poll said they currently have no health insurance and 56 percent said they've put off getting health care that they needed.
› Verified 6 days ago
Entity Name | Aloha Critical Care Associates Llp |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1245286772 PECOS PAC ID: 3870522956 Enrollment ID: O20050809000637 |
News Archive
An in-depth study on the regulation of adenosine-to-inosine (A-to-I) RNA editing by researchers from the Cancer Science Institute of Singapore at the National University of Singapore found that a protein, known as DHX9, acts as a bidirectional regulator of the molecular process which is linked to various types of cancer such as esophageal cancer.
Two chemical engineering professors at Rensselaer Polytechnic Institute are contributing to a collaboration among academia, industry, and the federal government to develop a method for rapidly manufacturing biologic drugs.
Lexicon Pharmaceuticals, Inc. announced today that it is progressing into the placebo-controlled portion of its Phase 2 clinical trial of LX4211 in patients with type 1 diabetes, having successfully completed the open-label, pioneer portion of the trial.
About half of the long-term unemployed and under-employed in a poll said they currently have no health insurance and 56 percent said they've put off getting health care that they needed.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Mark Anthony Valdez, MD 925 Edith Ave Apt O, Alhambra, CA 91803-2234 Ph: () - | Dr Mark Anthony Valdez, MD 888 S King St, Honolulu, HI 96813-3097 Ph: (808) 522-4000 |
News Archive
An in-depth study on the regulation of adenosine-to-inosine (A-to-I) RNA editing by researchers from the Cancer Science Institute of Singapore at the National University of Singapore found that a protein, known as DHX9, acts as a bidirectional regulator of the molecular process which is linked to various types of cancer such as esophageal cancer.
Two chemical engineering professors at Rensselaer Polytechnic Institute are contributing to a collaboration among academia, industry, and the federal government to develop a method for rapidly manufacturing biologic drugs.
Lexicon Pharmaceuticals, Inc. announced today that it is progressing into the placebo-controlled portion of its Phase 2 clinical trial of LX4211 in patients with type 1 diabetes, having successfully completed the open-label, pioneer portion of the trial.
About half of the long-term unemployed and under-employed in a poll said they currently have no health insurance and 56 percent said they've put off getting health care that they needed.
› Verified 6 days ago
Dr. Isac C. Thomas, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 3288 Moanalua Rd, Honolulu, HI 96819 Phone: 808-432-0000 | |
Nishal Brahmbhatt, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1301 Punchbowl St, Honolulu, HI 96813 Phone: 808-691-1000 | |
Dr. Thomas Jon Uyehara Wong, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1301 Punchbowl St, Honolulu, HI 96813 Phone: 808-691-1000 | |
Taryn Kikue Miyake, MD Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 1356 Lusitana St Fl 7, Honolulu, HI 96813 Phone: 808-586-2910 | |
Joshua Bruce Taylor, MD Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 1356 Lusitana St Fl 7, Honolulu, HI 96813 Phone: 520-909-7445 | |
Raja Haris Rizwan, MD Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 1356 Lusitana St Fl 7, Honolulu, HI 96813 Phone: 808-392-3286 | |
Dr. Elizabeth G Quinn, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1010 Pensacola St, Honolulu, HI 96814 Phone: 808-432-2303 |